​Noticias

La Nueva Ley De PI en Ecuador: Principales Cambios

El “Código Orgánico de la Economía Social de los Conocimientos, Creatividad e Innovación” se publicó el 9 de diciembre y reemplaza a la Ley de Propiedad Intelectual. Antecedentes Como miembro de la Comunidad Andina, rigen en Ecuador las Decisiones 345 (obtenciones vegetales), 351 (derechos de autor), 391 (conocimientos tradicionales) y 486 (propiedad industrial). Las Decisiones […]

Instructivo Para la Modificación de la Autorización de Comercialización de Medicamentos Luego de la Expiración de una Patente

La Agencia Nacional para el Control Sanitario, Regulación y Monitoreo (ARCSA) ha emitido un instructivo disponiendo un procedimiento relacionado a la modificación de la autorización de comercialización luego de la expiración de una patente, el cual se aplicará a todos los propietarios de autorizaciones de comercialización de medicamentos registrados en Ecuador cuyas patentes han expirado. […]

New Merger and Other Changes for 2017

2017 is set to be a monumental year for CorralRosales. Not only will I be taking up a position on the Board of Directors of the International Trademark Association on January 1st, but our firm will also be merging with fellow Ecuadorian IP law firm, Estudio Jurídico Gallegos. The merge officially took place on January […]

Reduction in Official Fees for Patents in Ecuador

Following a request from the European Union during commercial treaty negotiations with Ecuador, the Ecuadorian IP Office has issued Resolution No. 001-2016-CD-IEPI (the Resolution), through which it has significantly reduced the official fees applicable to patent applications and their maintenance. Below is an analysis as to the relevant changes:   Filing Fees Fee Former fee […]

Decree 1159 and Reference Medications

The Regulations Implementing the Law on Production, Import, Marketing and Sale of Generic Medicines for Human Use has seen a recent reform, in particular through Executive Decree 1159, which removes the requirement that ‘reference medications’, once the patent expires, must modify their product marketing authorization to comply with the labelling requirements of a generic product. […]

Normas Referentes a la Publicidad Exterior

Mediante Ordenanza Metropolitana No.119 se establece el régimen administrativo de la Licencia Metropolitana Urbanística de Publicidad Exterior para el Distrito Metropolitano de Quito.  La cual establece los siguientes parámetros sobre los cuales se puede colocar publicidad exterior en el Distrito Metropolitano de Quito. Se prohíbe con carácter general: La publicidad susceptible a crear miedo, alarma, […]

ARCSA Outlines Role of Manufacturers and Public in Controlling Counterfeits

The National Agency for Health Inspection, Regulation, and Monitoring (ARCSA), has recently issued a regulation relating to the control of counterfeit, adulterated, and altered products in Ecuador. ‘Adulterated’ products are defined through the regulation as those that have had their characteristics changed knowingly in some way, whereas ‘altered’ products are those products whose characteristics are […]

Landmark Criminal Action Initiated Against Counterfeiters

At the end of 2015, the District Attorney’s Office in Quito received an anonymous complaint alerting them to the sale of counterfeit pharmaceutical products. Following this complaint, on December 2, 2015 the National Police of Ecuador conducted several raids on various locations. These locations included a site where counterfeit pharmaceuticals were being manufactured, a site […]

Andean Community Issues Ruling on Patent Fees in Ecuador

The Andean Community Secretariat has issued a resolution rejecting the action brought on behalf of the Bolivarian University from Medellin, Colombia, seeking to lower patent official fees based on them being considered discriminatory and excessively high. [...]

Re-branding as Generics upon Expiration of Ecuadorian Patent

On January 15, 2015, Presidential Decree No. 522 amended the Regulations for the Application of the Law on Import, Commercialization and Sale of Generic Medicines for Human Use (the “Regulations”). The “New Rules” alter the practice in relation to the branding and trademarking of patented medicines after expiration of the patent. [...]